More about

Epinephrine

News
November 01, 2024
2 min read
Save

Top in allergy/asthma: Pediatric psychology referrals surge; esophagitis risk in children

 Top in allergy/asthma: Pediatric psychology referrals surge; esophagitis risk in children

A retrospective chart review revealed a 50% increase in outpatient pediatric psychology referrals from the Food Allergy Treatment Center between 2013 and 2023.

News
October 29, 2024
3 min read
Save

Q&A: Epinephrine auto-injectors may not be adequate in preventing fatal anaphylaxis

Q&A: Epinephrine auto-injectors may not be adequate in preventing fatal anaphylaxis

Epinephrine autoinjectors may be associated with short-lived peak plasma levels, unpredictable cardiovascular responses as well as varying epinephrine absorption, according to a review published in Clinical and Experimental Allergy.

News
October 24, 2024
4 min read
Save

Dry powder epinephrine nasal spray outcomes comparable with intramuscular injection

Dry powder epinephrine nasal spray outcomes comparable with intramuscular injection

BOSTON — An intranasal epinephrine powder produced responses that were comparable with intramuscular administration, according to a poster presented at the American College of Allergy, Asthma & Immunology Annual Scientific Meeting.

News
August 16, 2024
2 min read
Save

Top in allergy/asthma: FDA OKs neffy nasal spray; cleaning products pose risks for women

Top in allergy/asthma: FDA OKs neffy nasal spray; cleaning products pose risks for women

The FDA approved ARS Pharmaceuticals’ neffy epinephrine nasal spray for emergency allergic reactions in children and adults weighing at least 66 pounds.

News
August 16, 2024
6 min read
Save

Q&A: Physicians should ‘start small and local’ to advocate for themselves, patients

Q&A: Physicians should ‘start small and local’ to advocate for themselves, patients

Our political system ensures that everyone throughout the country has representation, Melinda M. Rathkopf, MD, MBA, told Healio. Leveraging that representation is essential when physicians need to advocate for their patients and themselves.

News
August 14, 2024
5 min read
Save

Advocates ‘very excited’ by FDA approval of epinephrine nasal spray

Advocates ‘very excited’ by FDA approval of epinephrine nasal spray

Advocates were pleased to learn about the FDA’s approval of ARS Pharmaceuticals’ neffy epinephrine nasal spray, which may have a significant impact on the safety and quality of life of families with allergy.

News
August 09, 2024
2 min read
Save

FDA approves epinephrine nasal spray for anaphylaxis

FDA approves epinephrine nasal spray for anaphylaxis

The FDA has approved neffy epinephrine nasal spray for emergency treatment of Type 1 allergic reactions, including anaphylaxis, in pediatric and adult individuals weighing at least 66 pounds.

News
July 24, 2024
3 min read
Save

Caregivers respond well after administering epinephrine during child oral food challenge

Caregivers respond well after administering epinephrine during child oral food challenge

Giving young children an epinephrine autoinjection can be a positive and confidence-boosting experience for families, according to a study published in The Journal of Allergy and Clinical Immunology: In Practice.

News
July 19, 2024
1 min read
Save

Top in allergy/asthma: Efficacy of dry powder nasal epinephrine; COVID-19 asthma outcomes

Top in allergy/asthma: Efficacy of dry powder nasal epinephrine; COVID-19 asthma outcomes

A crossover study revealed that dry powder epinephrine administered via nasal spray yielded drug exposures equal to or higher than those provided by autoinjectors in a canine model.

News
July 12, 2024
2 min read
Save

Top in allergy/asthma: EURneffy closer to approval; caregivers seek allergy info online

Top in allergy/asthma: EURneffy closer to approval; caregivers seek allergy info online

The European Medicines Agency Committee for Medicinal Products for Human Use has recommended marketing authorization of ARS Pharmaceuticals’ EURneffy epinephrine nasal spray in the European Union, according to a press release.

View more